|
1. |
Treatment of Advanced Colorectal Cancer with Recombinant Interferon Alpha and Fluorouracil: Activity in Liver Metastasis |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 259-264
RubioE. Diaz,
JimenoJ.,
CampsC.,
ArandaE.,
MassutiB.,
BlancoE.,
AntónA.,
LízonJ.,
LarribaJ.L. González,
Preview
|
PDF (401KB)
|
|
摘要:
A cohort of 35 patients with advanced colorectal cancer, not previously exposed to chemotherapy, were included in a phase II study exploring the combination ofinterferon-alpha, 9 MU subcutaneously three times weekly, and 5-fluorouracil 750 mg/nf/day during 5 consecutive days in continuous intravenous infusion followed with weekly bolus injection offluorouracil 750mg/m2. Of 33 cases evaluablefor activity; 5 patients achieved partial response and 3 complete response for an overall response rate of 24% (95%; confidence limit 11-42 %). Most of the responses were observed in liver metastases, response rate = 30% (95%; CL 13-53%), with little activity observed in other sites; response rate 3% (95%; CL 8-16%), p =. 0006. The median time to progression and median overall survival were 16+ (range 1+ to 48+) and 21+ weeks (range 1+ to 52+). All patients were evaluablefor analysis of toxicity. Severe mucositis and diarrhea, present in 14 patients were the limiting side effects. Two patients developed progressive renal toxicity and died. Weakness, myalgia, and nonneutropenic fever were observed frequently, one patient developed dementia. This combination is able to induce major responses in patients with advanced colorectal cancer, particularly in liver metastasis. Additional trials evaluating this approach are indicated.
ISSN:0735-7907
DOI:10.3109/07357909209032749
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
2. |
Preliminary Evidence that Incorporation of 5-Fluorouracil into RNA Correlates with Antitumor Response |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 265-269
MatsuokaHideo,
UeoHiroaki,
SugimachiKeizo,
AkiyoshiTsuyoshi,
Preview
|
PDF (313KB)
|
|
摘要:
A comparative study of two different species ofafluorouracil assay was conducted on 11 patients who had carcinoma that was deemed unresectable after the surgical operation. For these patients FU at a dose of 10 mg/kg was intravenously administered before operation, and portions of the tumors were resected within 120-150 min to assay both the (FU)RNA/RNA and FU/protein. After surgery, all patients were given FU alone either intravenously or orally. The FU, which was in an acid-soluble material (FU/protein), was not related to the antitumor effect ofFU. However, the FU in RNA f(FU)RNA/RNA)] was found to be related to the antitumor effect ofFU. When the concentration of (FU)RNAZRNA was above approximately 200 ng/mg, FU was effectual in unresectable carcinomas. It is probable that the (FU)RNAZRNA may be more suitable than FU/protein for predicting the antitumor effect of FU.
ISSN:0735-7907
DOI:10.3109/07357909209032750
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
3. |
Treatment with ImuVert/JV-Acetylcysteine Protects Rats from Cyclophosphamide/ Cytarabine-Induced Alopecia |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 271-276
JimenezJoaquin J.,
ShengHui,
YunisAdel A.,
Preview
|
PDF (603KB)
|
|
摘要:
Chemotherapy-induced alopecia is a distressing problem to the cancer patient for which currently there is no effective preventive measure. Recently hnuVert, a biologic response modifier, has been shown to protect from cytarabine-induced alopecia in the young rat model, but not from alopecia induced by cyclophosphamide. In the present study, the rat model was used to examine the effect of N-acetylcysteine on the course of alopecia from cyclophosphamide and of ImuVert plus N-acetylcysteine on alopecia induced by cytarabine-cyclophosphamide combination. The following observations were made: (1) Cyclophosphamide-induced alopecia could be effectively prevented by N-acetylcysteine, administeredparenterally or applied topically in liposomes. (2) Alopecia caused by the combination of cyclophosphamide and cytarabine could be prevented by the parenteral or topical administration of ImuVert plus N-acetylcysteine. The potential applicability of these observations to the clinical setting remains to be determined.
ISSN:0735-7907
DOI:10.3109/07357909209032751
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
4. |
Hyperthermic Isolation Limb Perfusion for Malignant Melanoma: A Review |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 277-284
CoitDaniel G.,
Preview
|
PDF (720KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909209032752
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
5. |
Possibilities for Active Immunotherapy of Human Cancer |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 285-293
HellströmKarl Erik,
HellströmIngegerd,
Preview
|
PDF (938KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909209032753
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
6. |
Photoaffinity Labeling of P-Glycoprotein in Multidrug-Resistant Cells |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 295-305
SafaAhmad R.,
Preview
|
PDF (1205KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909209032754
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
7. |
New Therapies for Ovarian Cancer |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 307-315
SchilderRussell J.,
OzolsRobert F.,
Preview
|
PDF (965KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909209032755
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
8. |
Treatment of Intractable Dyspnea: Clinical and Ethical Issues |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 317-321
CohenMartin H.,
JohnstonAnita,
KrasnowSteven H.,
WadleighRobert G.,
Preview
|
PDF (467KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909209032756
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
9. |
Back to the Future: New Theories on 5-Fluorouracil/Interferon Interactions |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 323-326
WadlerScott,
Preview
|
PDF (325KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909209032757
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
10. |
Oncology Drug Discovery and Clinical Trial Testing: Who's Listening? |
|
Cancer Investigation,
Volume 10,
Issue 4,
1992,
Page 327-329
SeitzDavid E.,
Preview
|
PDF (242KB)
|
|
ISSN:0735-7907
DOI:10.3109/07357909209032758
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
|